Cart
sales@molnova.com
Diatrizoate meglumine
CAS No. 131-49-7
Diatrizoate meglumine( Hypaque | Reno | Renocal | Renografin | Renovist | Sinografin )
Catalog No. M23475 CAS No. 131-49-7
Diatrizoate meglumine is the meglumine salt of diatrizoate, it is an organic, iodinated, radiopaque X-ray contrast medium used in diagnostic radiography.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 29 | In Stock |
|
| 1G | 41 | In Stock |
|
Biological Information
-
Product NameDiatrizoate meglumine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiatrizoate meglumine is the meglumine salt of diatrizoate, it is an organic, iodinated, radiopaque X-ray contrast medium used in diagnostic radiography.
-
DescriptionDiatrizoate meglumine is the meglumine salt of diatrizoate, it is an organic, iodinated, radiopaque X-ray contrast medium used in diagnostic radiography.
-
In Vitro——
-
In Vivo——
-
SynonymsHypaque | Reno | Renocal | Renografin | Renovist | Sinografin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number131-49-7
-
Formula Weight809.13
-
Molecular FormulaC18H26I3N3O9
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peterson CM, Lin M, Pilgram T, Heiken JP. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. J Comput Assist Tomogr. 2011 Mar-Apr;35(2):202-5.
molnova catalog
related products
-
E-3030
E-3030 free acid is a potent dual activator of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma, exhibiting significant antidiabetic and lipid-modulating effects. E-3030 decreases blood glucose, triglyceride, non-esterified fatty acids, and insulin levels, while increasing blood adiponectin levels. E-3030 improves glucose tolerance and shows remarkable triglyceride- and non-high-density lipoprotein cholesterol-lowering effects in animal models.
-
[D-Phe7, D-Trp10]-So...
[D-Phe7, D-Trp10]-Somatostatin 14 (7-14)
-
Zelminemab
Zelminemab (AMG-301) is a human monoclonal antibody designed to target and inhibit the PACAP type I (PAC1) receptor .
